Top Markets
Coin of the day
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Rang in Aktien #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Aktienkurs
$5.84
Zuletzt synchronisiert: 2025-04-02
Marktkapitalisierung
$224.09M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Nevro Corp. (NVRO)

Kategorie

Kursverlauf für Nevro Corp. (NVRO)
Höchster Schlusskurs: $5.84 am 2025-04-01

Niedrigster Schlusskurs: $26.25 am 2014-11-01
Kursverlauf der Aktie von Nevro Corp. von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 45.15%
2024 -80.60%
2023 -49.87%
2022 -52.05%
2021 -49.43%
2020 51.22%
2019 187.70%
2018 -43.56%
2017 -6.49%
2016 13.88%
2015 84.90%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$110.59 -16.34%
US
$312.39 -19.60%
US
$92.11 -0.15%
IE
$48.42 -54.97%
US
$90.87 11.88%
US